Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00835952 · ClinicalTrials.gov registry record · Phase 1
ATX-101 Abdominoplasty
A Phase 1 study of Characteristics of Subcutaneous Fat, sponsored by Kythera Biopharmaceuticals.
- Completed
- Registry status
- Phase 1
- Development phase
- 14
- Enrollment target
- 2
- Study locations
NCT00835952: Completed Phase 1 study of Characteristics of Subcutaneous Fat, sponsored by Kythera Biopharmaceuticals.
NCT00835952 is a Phase 1 study of Characteristics of Subcutaneous Fat that has completed, run by Kythera Biopharmaceuticals. The registered enrollment target is 14 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (77% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00835952, a Phase 1 study of Characteristics of Subcutaneous Fat, has completed, sponsored by Kythera Biopharmaceuticals.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 14 participants
- Enrollment target
- 2
- Study locations
Study Summary
Histopathological study of abdominal fat excised from subjects undergoing abdominoplasty
Conditions Studied
Interventions
- DRUG ATX-101
Study Locations (2)
California
- - San Francisco
- - Santa Monica
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2008-11 |
| Est. Completion | 2009-04 |
| Phase | Phase 1 |
What the finished NCT00835952 record still lists
NCT00835952 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 14 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Characteristics of Subcutaneous Fat appearing as the primary indexed condition, and to 1 intervention - of which ATX-101 is the first listed.
NCT00835952 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT00835952 about?
NCT00835952 is a clinical study titled "ATX-101 Abdominoplasty". Histopathological study of abdominal fat excised from subjects undergoing abdominoplasty
What is the current status of trial NCT00835952?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 14 participants. The study started on 2008-11. Estimated completion is 2009-04.
What conditions does trial NCT00835952 study?
This clinical trial studies the following conditions: Characteristics of Subcutaneous Fat.
What interventions are being tested in trial NCT00835952?
The interventions under investigation include: ATX-101 (DRUG).
Who is sponsoring clinical trial NCT00835952?
This trial is sponsored by Kythera Biopharmaceuticals, which has 19 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00835952 being conducted?
This trial has 2 study locations across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00835952's enrollment target sits among peer trials
14 1844th of 2000 higher than 154 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02523092 · 14 participants · Phase 4
Use of CXCL9 as a Biomarker of Acthar Efficacy
- NCT04263285 · 14 participants · NA
Treatment of Depression Post-SCI
- NCT04743271 · 14 participants · NA
Food and Circadian Timing
- NCT05065671 · 14 participants · Phase 1
Microbiome Derived Metabolism and Pharmacokinetics
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia